EMPA-KIDNEY: Empagliflozin Slows Progression of CKD

The EMPA-KIDNEY study adds to existing evidence for the benefit of SGLT2 inhibitors in slowing the progression of chronic kidney disease.

HCM Hot Topic Tuesdays: Has the Treatment Strategy Changed?

This webinar focuses on medical treatment strategies for obstructive HCM, as part of the Accelerating Innovation for Medical Excellence in Hypertrophic Cardiomyopathy initiative.

Join Your Colleagues in New Orleans or Virtually!

Get everything you need to advance cardiovascular care for all at ACC.23 Together With WCC! Register now and get a 1-year subscription to ACC Anywhere included for FREE!

Latest In Cardiology

Products

Engage

Quick Links

Events and Conferences

Join

Memberships

Fellow of the ACC (FACC)

Earn the ultimate recognition. Fellowship identifies you to peers and patients as a cardiovascular professional at the top of your field.

Cardiovascular Team

Join a vibrant community of nurses, PAs, clinical pharmacists, technologists and rehab specialists.

International Associate

Join a global community dedicated to reducing the burden of CV disease worldwide and access resources that help you advance your knowledge and expand your network.

Benefits

Unlock access to all 10 JACC Journals, exclusive networking opportunities with 54,000 cardiovascular professionals, deep discounts on educational opportunities and more.

Learn More  
Nkechinyere Ijioma
The ACC is our community to learn from one another and grow with each other. United, we have the ability to advocate for our patients and profession. Nkechinyere Ijioma, MBBS, FACC

ACC Digital Family